Listening to patients has been at the heart of our research efforts since our company’s inception. We are determined to respond to the needs of children with severe and highly treatment-resistant forms of epilepsy.
TakeOnEpilepsy.com is a unique online destination with vital resources for those living with serious conditions such as Dravet Syndrome, Lennox-Gastaut syndrome and Tuberous Sclerosis Complex.
In developing this site, we partnered with various advocacy groups, caregivers, and patients to gain insights and better understand their unmet needs. The information and the resources provided are directly based on the input we received by reaching out and listening to these communities.
There are a number of organizations which provide invaluable help, information, and support to people living with epilepsy. They are also a useful resource for caregivers, friends, and relatives. The following list includes links to some websites of patient organizations that may be useful.
- Epilepsy Foundation
- Dravet Syndrome Foundation
- Lennox-Gastaut Syndrome Foundation
- Tuberous Sclerosis Alliance
- Child Neurology Foundation
Maintaining our focus on the potential benefit to patients has been a consistent driving force in our research program and progress to date. We are in a unique position to develop and manufacture consistent cannabinoid formulations worldwide at sufficient quality, uniformity and scale to meet international regulatory requirements.
We are committed to respecting the primary role of healthcare providers in the treatment of epilepsy disorders. Therefore, we cannot respond to medical questions about your personal health situation, nor can we accept private medical information. Please contact your healthcare provider with any questions pertaining to your or a family member's medical condition and ongoing clinical trials.